scispace - formally typeset
M

Matilde Todaro

Researcher at University of Palermo

Publications -  163
Citations -  19136

Matilde Todaro is an academic researcher from University of Palermo. The author has contributed to research in topics: Cancer stem cell & Stem cell. The author has an hindex of 55, co-authored 154 publications receiving 17289 citations. Previous affiliations of Matilde Todaro include University of Rome Tor Vergata.

Papers
More filters
Journal ArticleDOI

Identification and expansion of human colon-cancer-initiating cells

TL;DR: It is concluded that colorectal cancer is created and propagated by a small number of undifferentiated tumorigenic CD133+ cells, which should therefore be the target of future therapies.
Journal ArticleDOI

Wnt activity defines colon cancer stem cells and is regulated by the microenvironment

TL;DR: It is proposed that stemness of colon cancer cells is in part orchestrated by the microenvironment and is a much more dynamic quality than previously expected that can be defined by high Wnt activity.
Journal ArticleDOI

Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells

TL;DR: A variable number (range 20–90%, mean 60.7%) of endothelial cells in glioblastoma carry the same genomic alteration as tumour cells, indicating that a significant portion of the vascular endothelium has a neoplastic origin.
Journal ArticleDOI

Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4.

TL;DR: The data suggest that colon tumor growth is dictated by stem-like cells that are treatment resistant due to the autocrine production of IL-4, which strongly enhances the antitumor efficacy of standard chemotherapeutic drugs through selective sensitization of CD133(+) cells.
Journal ArticleDOI

Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity

TL;DR: In this article, the authors show that spheroid cultures of these colon CSCs contain expression of CD133, CD166, CD44, CD29, CD24, Lgr5, and nuclear β-catenin, which have all been suggested to mark the cancer stem cell population.